Nocturia Market

Nocturia Market to reach an estimated value of US$ 4.5 Bn by 2025
According to the latest market report published by Persistence Market Research, titled “Nocturia
Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026),” the global nocturia
market is expected to expand at a CAGR of 7.5% during the forecast period 2017–2026. In 2017,
the global market was valued at around US$ 2,500 Mn and is estimated to reach a valuation higher
than US$ 4.5 Bn by the end of the forecast period.
On the basis of indication type, the market is segmented into mixed nocturia, low nocturnal bladder
capacity, nocturnal polyuria and global polyuria. The low nocturnal bladder capacity segment is
estimated to be the largest with a high market value and is projected to grow at a significant CAGR
throughout the period of forecast. The nocturnal polyuria segment is projected to be the fastest
growing and is expected to register a CAGR of 7.8% during the forecast period.
Report overview @ https://www.persistencemarketresearch.com/market-research/nocturiamarket.asp
Based on drug type the market is segmented as anticholinergic drugs, desmopressin, antibiotics,
antispasmodic and others. Desmopressin segment is poised to dominate the global market from a
market value perspective. This segment reflected a market share of 31.6% in 2017, however it is
expected to lose BPS by the end of the forecasted year.
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies,
drug stores and online pharmacies. Hospital pharmacies is expected to hold major market share and
registering CAGR of 8.1% in terms of value, over the forecast period owing to the increasing focus
of availability. The online pharmacies segment is expected to gain high traction in the coming years
and is projected to grow at a high CAGR of 8.4% during the period of forecast.
Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/20806
On the basis of region, the market has been segmented into North America, Latin America, Europe,
Asia-Pacific, and the MEA. North America region led the nocturia market since past years and is
likely to continue to dominate the overall market due to higher awareness and entry of players into
the market by launching different products.
Companies are focusing on collaboration to develop new more effective products. The product type
segment of nocturia will be boosted by its higher response rate and increasing research activities for
R&D leading to inorganic growth.
The global nocturia market is highly fragmented owing to the presence of various companies such
Allergan, Inc., Urigen Pharmaceuticals, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Inc.,
Teva Pharmaceutical Industries Ltd., AA Pharma Inc. and Avadel Pharmaceuticals plc.
Get Full Report now @ https://www.persistencemarketresearch.com/checkout/20806
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses achieve
optimal performance.To support companies in overcoming complex business challenges, we follow
a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional
sources. By deploying real-time data collection, big data, and customer experience analytics, we
deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com